Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AINovo Biotech leverages proprietary generative AI and machine learning platforms to accelerate the discovery and optimization of novel biologic therapeutics and diagnostics. The company has demonstrated proof-of-concept by developing a patent-pending diagnostic for lung cancer. Its technology enables rapid candidate selection in both biopharma and agricultural biotech sectors, with ongoing collaborations but no published late-stage clinical results as of now.[1][3][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AINovo Biotech Inc..